• Lonnie Granier

Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

TUESDAY, MARCH 2nd / 12:00-1:00pm CT

Overdose deaths associated with illicit stimulants have surged in the past eight years, according to a recent study by the National Institutes for Health (NIH). While there are currently no FDA-approved medications for the treatment of individuals who are dependent on stimulants, new treatments utilizing readily available medications are showing encouraging empirical support.

Join the National Council for Behavioral Health as we examine the latest groundbreaking research in the context of current increases in stimulant use. Register here

1 view0 comments

Recent Posts

See All

SAMHSA Early Diversion Virtual Learning Community

Part 1: Strategies for Addressing Treatment Engagement Challenges with Certain Individuals THURSDAY, MARCH 25th / 1:00-2:00pm CT Many communities face challenges engaging certain individuals in treatm

Rural Health Challenges During COVID-19

THURSDAY, MARCH 11th / 1:00-2:00pm CT Rural America has suffered from a severe shortage in behavioral health providers for decades, and the COVID-19 pandemic has highlighted this inequity more than ev

Subscribe to Our Newsletter

© 2020 by CLASPP